Press Coverage October 4, 2022
Troutman Pepper Advises Renovacor in Acquisition by Rocket Pharmaceuticals
PHILADELPHIA – Troutman Pepper client Renovacor, Inc., a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, recently announced that it has entered into a definitive agreement to be acquired by Rocket Pharmaceuticals, Inc. Read a company press release about the acquisition.
Rocket Pharmaceuticals is a leading late-stage, clinical biotechnology company focused on advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need. The acquisition of Renovacor will strengthen Rocket Pharmaceuticals’ leadership position in AAV-based gene therapy for cardiac disease and allow the combined company to continue their mission to transform the lives of heart failure patients through the power of gene therapy.
The Troutman Pepper team advising Renovacor included Rachael Bushey, Jennifer Porter, Laura Umbrecht, Justin Platt, Stephanie Isaia, Brencis Navia, Alice Choi, David Taub, Alicia Worthy, Immanuel Kim, Joan Arnold, James Earle, Barbara Sicalides and Monika Chawla.
Troutman Pepper’s leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients’ complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm’s litigation, transactional, and regulatory practices advise a diverse client base, from startups to multinational enterprises. The firm provides sophisticated legal solutions to clients’ most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
Insight Industries + Practices
Speaking Engagements
Performance on Trial: The Construction Manager’s Standard of Care Examined from All Angles
December 2, 2026 | 4:15 PM – 5:30 PM ET
The Hyatt Regency Huntington Beach
Huntington Beach, CA
Speaking Engagements
ACI’s 31st Annual Conference on Drug & Medical Device Litigation – 2026
December 2 – 3, 2026
New York Marriott Marquis
1535 Broadway, New York, NY 10036
Speaking Engagements
Fundamentals of Investment Adviser Regulation 2026
November 19, 2026 | 2:30 PM – 3:30 PM ET
PLI New York
1177 Avenue of the Americas, Entrance on 45th Street, New York, NY 10036
Speaking Engagements
2026 Advanced eDiscovery Institute
November 19 – 20, 2026
Capital Hilton
1001 16th Street NW, Washington, DC 20036